Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.

A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Journal of Pharmacology and Experimental Therapeutics Pubmed

A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.

A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.

The Journal of Pharmacology and Experimental Therapeutics , Volume 329 (1): 251412 – Apr 28, 2009

Loading next page...
 
/lp/pubmed/a-novel-highly-selective-tight-binding-ikappab-kinase-2-ikk-2-WECUxor0oy

References (41)

eISSN
1521-0103
DOI
10.1124/jpet.108.143800
pmid
19168710
Publisher site
See Article on Publisher Site

Abstract

Journal

The Journal of Pharmacology and Experimental TherapeuticsPubmed

Published: Apr 28, 2009

There are no references for this article.